Mon, August 13, 2018
Fri, August 10, 2018
Thu, August 9, 2018
Wed, August 8, 2018
Tue, August 7, 2018
Mon, August 6, 2018
Fri, August 3, 2018
Thu, August 2, 2018
Wed, August 1, 2018
Tue, July 31, 2018

Liana Moussatos Maintained (BMRN) at Buy with Increased Target to $120 on, Aug 6th, 2018


//stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-120-on-aug-6th-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Liana Moussatos of Wedbush, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $115 to $120 on, Aug 6th, 2018.

Liana has made no other calls on BMRN in the last 4 months.



There are 5 other peers that have a rating on BMRN. Out of the 5 peers that are also analyzing BMRN, 0 agree with Liana's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Liana


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $115 on, Friday, August 3rd, 2018
  • Stephen Willey of "Stifel" Maintained at Strong Buy with Increased Target to $109 on, Friday, August 3rd, 2018
  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $113 on, Tuesday, July 31st, 2018
  • M. Auster of "Credit Suisse" Maintained at Buy with Increased Target to $122 on, Monday, July 9th, 2018
  • Cory Kasimov of "JP Morgan" Maintained at Buy with Increased Target to $133 on, Thursday, May 31st, 2018

Publication Contributing Sources

Similar Stocks and Investing Publications